Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-01-01 @ 5:25 PM
Study NCT ID:
NCT05918432
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-26
First Post:
2023-06-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Determining Patterns In Study Experiences of Neuroblastoma Patients
Sponsor:
Power Life Sciences Inc.
Organization:
Study Overview
Official Title:
Neuroblastoma Clinical Trials: Looking at Patterns About How Patients Feel About Participating in Clinical Trials
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Historically, participation in clinical research is highly skewed towards particular demographic groups of people.
This study will invite several participants to gather a wide range of information on clinical trial experiences for neuroblastoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of neuroblastoma.
The data collected from this study will help improve future outcomes for all neuroblastoma patients as well as those in under-represented demographic groups.
This study will invite several participants to gather a wide range of information on clinical trial experiences for neuroblastoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of neuroblastoma.
The data collected from this study will help improve future outcomes for all neuroblastoma patients as well as those in under-represented demographic groups.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: